Navigation Links
Boston University School of Medicine professor receives AACC's Van Slyke Award
Date:12/13/2010

(Boston) - Michael F. Holick, PhD, MD, a professor at Boston University School of Medicine (BUSM), is the recipient of the 2010 Van Slyke Award from the American Academy for Clinical Chemistry New York Metro Section. The award acknowledges outstanding contributions to the science of clinical chemistry and laboratory medicine.

Holick, an internationally renowned expert in vitamin D and skin research, was chosen to receive the award for his seminal contributions to laboratory medicine. He is a professor of medicine, physiology and biophysics, and director of the General Clinical Research Unit at BUSM and Director of the Bone Health Care Clinic at Boston Medical Center.

Since joining BUSM in 1987, Holick has initiated several successful clinical research programs. He helped pioneer the assays for vitamin D and its metabolites which are used worldwide to determine a patient's vitamin D status and to evaluate disorders of calcium and bone metabolism. He helped establish global recommendations for sensible sun exposure and vitamin D intake for children and adults. His psoriasis work with active vitamin D is considered to be at the forefront of research into the complex disease. The results of his programs have led to significant contributions to the basic science of vitamin D and significant new therapies for a wide variety of medical problems.

Holick has received numerous honors and awards including the Psoriasis Research Achievement Award from the American Skin Association in 2000, the Robert H. Herman Memorial Award in Clinical Nutrition from the American Society for Clinical Nutrition in 2002, the General Clinical Research Centers Program Award for Excellence in Clinical Research in 2006, the 2007 Linus Pauling Functional Medicine Award from the Institute for Functional Medicine, the DSM Innovation Award for international nutrition and the Linus Pauling prize for his contributions in human nutrition.


'/>"/>

Contact: Nathan Bliss
nathan.bliss@bmc.org
617-638-8490
Boston University Medical Center
Source:Eurekalert

Page: 1

Related biology news :

1. Boston Univ., Veterans Affairs find sports brain trauma may cause disease mimicking ALS
2. Worlds largest meeting of ear, nose and throat doctors to convene in Boston Sept. 26-29, 2010
3. Boston University School of Medicine researcher awarded the 2010 Avanti Award in Lipids
4. Boston University reseachers develop faster, cheaper DNA sequencing method
5. Grant brings real-world science to Boston classrooms
6. Boston University scientists first to see RNA network in live bacterial cells
7. Boston University engineer to use $2.5 million NIH grant to cells reaction to physical force
8. Boston University biomedical engineers teach bacteria to count
9. Boston College chemistry professor Udayan Mohanty receives a 2009 Guggenheim Fellowship
10. Experts converge at Arizona State University for first preventive cancer vaccine conference
11. University of Miami marine biology student wins Emmy Award for work on Changing Seas
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/12/2016)... WearablesResearch.com , a brand of Troubadour ... from the Q1 wave of its quarterly wearables survey. ... receptivity to a program where they would receive discounts ... company. "We were surprised to see that ... LaColla , CEO of Troubadour Research, "primarily because there ...
(Date:4/26/2016)... LONDON , April 26, 2016 ... EdgeVerve Systems, a product subsidiary of Infosys (NYSE: ... a partnership to integrate the Onegini mobile security ... (Logo: http://photos.prnewswire.com/prnh/20151104/283829LOGO ) The ... enhanced security to access and transact across channels. ...
(Date:4/14/2016)... , April 14, 2016 ... and Malware Detection, today announced the appointment of ... the new role. Goldwerger,s leadership appointment comes ... the heels of the deployment of its platform at ... behavioral biometric technology, which discerns unique cognitive and physiological ...
Breaking Biology News(10 mins):
(Date:6/27/2016)... June 27, 2016  Liquid Biotech ... funding of a Sponsored Research Agreement with The ... cells (CTCs) from cancer patients.  The funding will ... levels correlate with clinical outcomes in cancer patients ... will then be employed to support the design ...
(Date:6/24/2016)... June 24, 2016 Epic Sciences unveiled ... cancers susceptible to PARP inhibitors by targeting homologous ... (CTCs). The new test has already been incorporated ... multiple cancer types. Over 230 clinical ... response pathways, including PARP, ATM, ATR, DNA-PK and ...
(Date:6/23/2016)... ... June 23, 2016 , ... Mosio, ... second eBook, “Clinical Trials Patient Recruitment and Retention Tips.” Partnering with experienced clinical ... eBook by providing practical tips, tools, and strategies for clinical researchers. , “The ...
(Date:6/23/2016)... 23, 2016 /PRNewswire/ - FACIT has announced the ... biotechnology company, Propellon Therapeutics Inc. ("Propellon" or ... of a portfolio of first-in-class WDR5 inhibitors for ... as WDR5 represent an exciting class of therapies, ... medicine for cancer patients. Substantial advances have been ...
Breaking Biology Technology: